In a skeletal muscle‐specific Akt1 transgenic mouse, Akt1‐mediated growth of glycolytic muscle led to ameliorated obesity with improvement in insulin sensitivity and reductions in serum insulin and glucose.17, 18. The gene discussed is AKT1; the disease is obesity disorder.